Piperazine derivatives used as Cav2.2 calcium channel modulators

Details for Australian Patent Application No. 2009272762 (hide)

Owner Convergence Pharmaceuticals Limited

Inventors Cridland, Andrew Peter; Heer, Jag Paul; Page, Lee William; Nicholson, Neville Hubert; Vile, Sadie; Gleave, Robert James; Campbell, Alister; Beswick, Paul John

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009272762

PCT Pub. Number WO2010/007073

Priority 0813142.7 17.07.08 GB

Filing date 15 July 2009

Wipo publication date 21 January 2010

International Classifications

C07D 213/81 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/007073 Priority application(s): WO2010/007073

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009272764-Selective substance separation using modified magnetic particles

2009272751-Ballistic resistant articles comprising elongate bodies